Effect of Antagonist Start Day on Cycle Outcomes in Poor Responders

BACKGROUND: Despite the great advances in Assisted Reproductive Technologies (ART), management of poor responders has remained a great challenge. Gonadotropin releasing hormone antagonist (GnRH-ant) has been offered as a patient friendly protocol. In the literature, conflicting data exists about the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahyaoglu, Inci, Dogru, Hatice Y, Kaplanoglu, Iskender, Ozgu-Erdinc, Ayse Seval, Dilbaz, Serdar, Mollamahmutoglu, Leyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812400/
https://www.ncbi.nlm.nih.gov/pubmed/35197686
http://dx.doi.org/10.4103/jhrs.jhrs_75_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812400/
https://www.ncbi.nlm.nih.gov/pubmed/35197686
http://dx.doi.org/10.4103/jhrs.jhrs_75_21

Ejemplares similares